Orphan designation: fidanacogene elaparvovec Treatment of haemophilia B, 19/11/2018 Withdrawn | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 9 April 2024 - 13:55

Orphan designation: fidanacogene elaparvovec Treatment of haemophilia B, 19/11/2018 Withdrawn

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-18-2090

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters